Ohio identifies Vapen cartridge in health complaints, store closure

Vext confirms product identity after state probe

Vext Science identified a Vapen vape cartridge as the product connected to health complaints that prompted Ohio regulators to shutter a dispensary earlier this month. The Phoenix-based company released the disclosure Monday evening. That ended a week of speculation after the Ohio Division of Cannabis Control ordered a retail location closed on September 8 pending investigation.

Preliminary testing of retained samples showed no detectable contaminants, the company said. Ohio's DCC hasn't released findings from its independent laboratory analysis.

No contaminants detected in initial screening

Vext's internal testing found no heavy metals, pesticides, or microbial contaminants in retained product samples. The company used third-party laboratories to screen for the standard battery of adulterants required under Ohio's medical cannabis testing protocols.

That finding doesn't close the investigation. State regulators maintain independent testing authority, and patient symptoms may stem from factors not captured in routine contaminant panels—terpene oxidation byproducts, residual processing solvents below detection thresholds, or individual sensitivities that standard screens miss.

Dispensary closure remains in effect

The Ohio dispensary involved remains closed under a DCC compliance order issued September 8. Neither Vext nor state regulators have named the retail location. Ohio law allows the DCC to suspend operations when patient safety is at risk. Closures last until the agency completes its review and issues a final determination.

The closure affects patient access in a market where dispensary density remains low in rural counties. Ohio's 60 active dispensaries serve roughly 180,000 registered medical patients, according to August state data.

Patient complaints trigger regulatory action

Multiple patients reported adverse reactions following use of the Vapen cartridge. That's what kicked off the investigation. Vext didn't specify the number of complaints or the nature of symptoms. Ohio's DCC hasn't issued a public health alert, suggesting the scope remains limited to a single batch or production run.

Vapen cartridges are sold in multiple Ohio dispensaries under licensing agreements with local cultivators and processors. The brand, owned by Vext, has faced product recalls in Arizona and Nevada in prior years, though none involved patient harm.

Regulatory scrutiny tightens in Ohio

Ohio has issued four product recalls in 2026, double the number from the prior year, as the state ramps up post-market surveillance ahead of adult-use launch. The DCC expanded its compliance staff by 12 investigators in July, funded by a $4.8 million allocation from the state legislature.

Voters approved adult-use legalization in November 2023. Sales are expected to begin in early 2027. The agency has signaled zero tolerance for supply-chain lapses as it transitions to a market projected to exceed $1 billion in annual sales within two years. For full background on this story, see the CannIntel topic hub on Ohio cannabis safety and recalls.

What operators should watch

Vext said it's cooperating fully with Ohio regulators and expects state lab results within 10 business days. The company hasn't announced a voluntary recall, suggesting it believes the issue is isolated. If DCC testing replicates Vext's clean results, attention will shift to batch-level manufacturing records and environmental controls during production.

The next signal: whether Ohio expands the investigation to other Vapen products or limits findings to a single SKU. Operators with Vapen inventory should prepare for potential state audits of chain-of-custody documentation.